OnKure | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Conferences

23 October 2024

Triple meeting 2024 – Cogent diversifies

Trial results

8 February 2024

KRAS and conjugates remain hot

The latest clinical study listings reveal KRAS-targeting projects, ADCs and others starting phase 1.

Subscribe to OnKure